Clinical and Demographical Characteristics of Patients with Medication Overuse Headache in Argentina and Chile: Analysis of the Latin American Section of COMOESTAS Project

Journal of Headache and Pain

Volumn 16, Issue 1, 2015, Pages

  Shand, Beatriz ^a   Goicochea, Maria Teresa ^b   Valenzuela, Raul ^a   Fadic, Ricardo ^a   Jensen, Rigmor ^c   Tassorelli, Cristina ^d,e   Nappi, Giuseppe ^d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b FLENI   (Argentina)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^e UNIVERSITY OF PAVIA   (Italy)

Author keywords

Chronic headache; Ergotamine; Medication Overuse Headache (MOH)

Indexed keywords

ERGOTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; TRIPTAN DERIVATIVE; ANALGESIC AGENT; TRYPTAMINE DERIVATIVE;

ADULT; AGED; ANXIETY DISORDER; ARGENTINA; ARTICLE; CHILE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEPRESSION; DRUG INDUCED HEADACHE; EMOTIONAL STRESS; EPISODIC TENSION HEADACHE; FEMALE; HUMAN; HYPERTENSION; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MOOD DISORDER; ONSET AGE; PRIMARY HEADACHE; PRIORITY JOURNAL; ADOLESCENT; CHEMICALLY INDUCED; ELECTRONIC HEALTH RECORD; HEADACHE DISORDERS, SECONDARY; MENTAL STRESS; MIDDLE AGED; MIGRAINE; PRESCRIPTION DRUG OVERUSE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALGESICS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARGENTINA; CHILE; ELECTRONIC HEALTH RECORDS; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PRESCRIPTION DRUG OVERUSE; SLEEP INITIATION AND MAINTENANCE DISORDERS; STRESS, PSYCHOLOGICAL; TRYPTAMINES; YOUNG ADULT;

EID: 84942237220     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1186/s10194-015-0561-1     Document Type: Article

References (24)

1. Munskgaard S, Jensen R (2014) Medication overuse headache. Headache 54(7):1251–1257
2. Silberstein S (2003) Chronic daily headache. Continuum: Headache Update 9:121–143
3. Zeeberg P, Olesen J, Jensen R (2005) Efficacy of multidisciplinary treatment in a tertiary referral headache centre. Cephalalgia 25(12):1159–1167
4. Diener HC, Limmroth V (2004) Medication-overuse headache: a worldwide problem. Lancet Neurol 3(8):475–483
5. Haag G, Baar H, Grotemeyer KH et al. (1999) Prophylaxis and treatment of drug-induced persistent headache. Therapy recommendation of the German Society for Migraine and Headache. Schmerz 13(1):52–57
6. Kristoffersen E, Lundqvist C (2014) Medication-overuse headache: a review (2014). J Pain Res 26:367–378
7. Ghiotto N, Sances G, Galli F et al. (2009) Medication overuse headache and applicability of the ICHD-II diagnostic criteria: 1-year follow-up study (CARE I protocol). Cephalalgia 29:233–243
8. Katsarava Z, Obermann M (2013) Medication-overuse headache. Curr Opin Neurol 26(3):276–281
9. Hagen K, Linde M, Steiner T et al (2012) Risk factor for medication-overuse headache: an 11 year- follow-up study. The Nord- Trondelag Health Studies. Pain 153:56–61
10. Zebenholzer K, Andree C, Lechner A, Broessner G, Lampl C, Luthringshausen G, Wuschitz A, Obmann SM, Berek K, Wöber C (2015) Prevalence, management and burden ofepisodic and chronic headaches--a cross-sectional multicentre study in eightAustrian headache centres. J Headache Pain 16:531
11. Westergaard ML, Glümer C, Hansen EH, Jensen RH (2014) Prevalence of chronic headache with and without medication overuse: associations with socioeconomic position and physical and mental health status. Pain 155:2005–2013
12. Steiner TJ, Stovner LJ, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Barré J, Andrée C (2014) The impact ofheadache in Europe: principal results of the Eurolight project. J Headache Pain 15:31
13. Vinding GR, Zeeberg P, Lyngberg A et al. (2007) The burden of headache in a patient population from a specialized headache centre. Cephalalgia 27(3):263–270
14. Rapoport A, Stang P, Gutterman DL, Cady R, Markley H, Weeks R et al. (1996) Analgesic rebound headache in clinical practice: data from a physician survey. Headache 36(1):14–19
15. Nogales-Gaete J (1992) Jaqueca por dependencia de tartrato de ergotamina. Rev Med Chile 120(7):797–799
16. Castillo J, Muñoz P, Guitera V et al. (1999) Epidemiology of chronic daily headache in general population. Headache 39(3):190–196
17. Bendtsen L, Munksgaard S, Tassorelli C et al. (2014) Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia 34(6):426–433
18. Tassorelli C, Jensen R, Allena M et al. (2014) A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia 34(9):645–655
19. Headache Classification Committee of the International Headache Society (IHS) (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33:629–808
20. Headache Classification Committee of International Headache Society (2004) The International Classification of Headache Disorders. 2nd ed. Cephalalgia 24(Suppl 1):1–160
21. Headache Classification Committee (2006) New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 26:742–746
22. Jonsson P, Linde M, Hensing G, Hedenrud T (2012) Sociodemographic differences inmedication use, health-care contacts and sickness absence among individuals with medication-overuse headache. J Headache Pain 13(4):281–290
23. Diener HC, Dahlöf CGH (1999) Headache associated with chronic use of substances. In: Oleson J, Tfelt-Hansen P, Welch KMA (eds) The headaches, 2nd edn. Lippincott, Philadelphia, pp 871–878
24. Atasoy HT, Atasoy N, Unal AE, Emre U, Sumer M (2005) Psychiatric comorbidity inmedication overuse headache patients with pre-existing headache type of episodic tension-type headache. Eur J Pain 9(3):285–291